914 related articles for article (PubMed ID: 21701511)
21. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.
McHugh PJ; Spanswick VJ; Hartley JA
Lancet Oncol; 2001 Aug; 2(8):483-90. PubMed ID: 11905724
[TBL] [Abstract][Full Text] [Related]
22. What is the DNA repair defect underlying Fanconi anemia?
Duxin JP; Walter JC
Curr Opin Cell Biol; 2015 Dec; 37():49-60. PubMed ID: 26512453
[TBL] [Abstract][Full Text] [Related]
23. C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair.
Collis SJ; Barber LJ; Ward JD; Martin JS; Boulton SJ
DNA Repair (Amst); 2006 Nov; 5(11):1398-406. PubMed ID: 16914393
[TBL] [Abstract][Full Text] [Related]
24. And-1 Coordinates with the FANCM Complex to Regulate Fanconi Anemia Signaling and Cisplatin Resistance.
Zhang Y; Li J; Zhou Y; Li Z; Peng C; Pei H; Zhu W
Cancer Res; 2022 Sep; 82(18):3249-3262. PubMed ID: 35867033
[TBL] [Abstract][Full Text] [Related]
25. Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.
Nishimura K; Ishiai M; Horikawa K; Fukagawa T; Takata M; Takisawa H; Kanemaki MT
Mol Cell; 2012 Aug; 47(4):511-22. PubMed ID: 22771115
[TBL] [Abstract][Full Text] [Related]
26. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.
Karanja KK; Lee EH; Hendrickson EA; Campbell JL
Cell Cycle; 2014; 13(10):1540-50. PubMed ID: 24626199
[TBL] [Abstract][Full Text] [Related]
27. The Fanconi anemia pathway and ICL repair: implications for cancer therapy.
Wang LC; Gautier J
Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):424-39. PubMed ID: 20807115
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
29. Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks.
Mason JM; Sekiguchi JM
Hum Mol Genet; 2011 Jul; 20(13):2549-59. PubMed ID: 21478198
[TBL] [Abstract][Full Text] [Related]
30. The Fanconi anaemia pathway: new players and new functions.
Ceccaldi R; Sarangi P; D'Andrea AD
Nat Rev Mol Cell Biol; 2016 Jun; 17(6):337-49. PubMed ID: 27145721
[TBL] [Abstract][Full Text] [Related]
31. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation.
Demuth I; Digweed M; Concannon P
Oncogene; 2004 Nov; 23(53):8611-8. PubMed ID: 15467758
[TBL] [Abstract][Full Text] [Related]
32. Trans-dichlorooxovandium (IV) complex as a novel photoinducible DNA interstrand crosslinker for cancer therapy.
Somyajit K; Banik B; Saxena S; Babu S; Hande MP; Chakravarty AR; Nagaraju G
Carcinogenesis; 2016 Feb; 37(2):145-156. PubMed ID: 26678223
[TBL] [Abstract][Full Text] [Related]
33. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells.
Nojima K; Hochegger H; Saberi A; Fukushima T; Kikuchi K; Yoshimura M; Orelli BJ; Bishop DK; Hirano S; Ohzeki M; Ishiai M; Yamamoto K; Takata M; Arakawa H; Buerstedde JM; Yamazoe M; Kawamoto T; Araki K; Takahashi JA; Hashimoto N; Takeda S; Sonoda E
Cancer Res; 2005 Dec; 65(24):11704-11. PubMed ID: 16357182
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
[TBL] [Abstract][Full Text] [Related]
35. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
[TBL] [Abstract][Full Text] [Related]
36. Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.
Ho TV; Schärer OD
Environ Mol Mutagen; 2010 Jul; 51(6):552-66. PubMed ID: 20658647
[TBL] [Abstract][Full Text] [Related]
37. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
Landais I; Sobeck A; Stone S; LaChapelle A; Hoatlin ME
Int J Cancer; 2009 Feb; 124(4):783-92. PubMed ID: 19048618
[TBL] [Abstract][Full Text] [Related]
38. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
Bhattacharjee S; Nandi S
Cell Commun Signal; 2017 Oct; 15(1):41. PubMed ID: 29017571
[TBL] [Abstract][Full Text] [Related]
39. Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.
Federico MB; Campodónico P; Paviolo NS; Gottifredi V
Mutat Res; 2018 Mar; 808():83-92. PubMed ID: 29031493
[TBL] [Abstract][Full Text] [Related]
40. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
